IndraLab

Statements

K(+) channel regulator 1 inhibits KCNH2. 1 / 1

| 1

reach

"Previous reports demonstrated that K (+) channel regulator 1 (KCR1) diminishes KCNH2 drug sensitivity and may protect susceptible patients from developing aLQTS."

20950623

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

K(+) channel regulator 1 inhibits KCNH2. 1 / 1

INDRA sources:

Databases

Reading